Anal Cancer - 79 Studies Found

Recruiting : Pembrolizumab in Refractory Metastatic Anal Cancer
: Anal Cancer
: 2016-09-02
: Drug: Pembrolizumab Pembrolizumab 200 mg will be administered as a 30 minute IV infusion every 3 weeks.
Recruiting : Shared Decision Making With Anal Cancer Patients on Radiation Dose
: Anal Cancer
: 2016-05-09
:
  • Radiation: 2.15 gray and 1.8 gray. Max. 6 weeks.
Completed : Anal Cancer Screening Study
: Anal Cancer
: 2009-06-04
Completed : Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer
: Anal Cancer
: 2009-08-07
:
  • Biological: cetuximab
  • Drug: cisplatin
Terminated : Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
: Anal Cancer
: 2003-09-10
:
  • Drug: cisplatin
  • Drug: fluorouracil
Completed : Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men
: Anal Cancer
: 2007-07-12
Recruiting : Anal Cancer Radiotherapy Study
: Anal Cancer
: 2013-08-28
Completed : Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer
: Anal Cancer
: 2001-10-11
:
  • Drug: cisplatin
  • Drug: fluorouracil
Recruiting : Individual Following in Anal Cancer With PET/CT
: Anal Cancer
: 2016-02-22
: Other: anal cancer Anal cancer patients with TEP TDM
Active, not recruiting : A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
: Anal Cancer
: 2012-08-07
:
  • Biological: Treatment ADXS11-0
Next >>>